- Home
- ACOG
as 03-25-2025 11:30am EST
Stocks
Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.
| Founded: | 2000 | Country: | Canada |
| Employees: | N/A | City: | VANCOUVER |
| Market Cap: | 91.6M | IPO Year: | N/A |
| Target Price: | $20.00 | AVG Volume (30 days): | 34.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.66 - $7.00 | Next Earning Date: | 05-20-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Alpha Cognition Inc. Common Stock News
ACOG Breaking Stock News: Dive into ACOG Ticker-Specific Updates for Smart Investing
Business Wire
7 days ago
Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview
MT Newswires
8 days ago
Alpha Cognition Launches Zunveyl for Treating Alzheimer's Disease; Shares Up Pre-Bell
Business Wire
8 days ago
Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease
Insider Monkey
21 days ago
Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory
Simply Wall St.
a month ago
Alpha Cognition Inc. (NASDAQ:ACOG) surges 13%; retail investors who own 46% shares profited along with institutions
Business Wire
a month ago
Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s disease
Newsfile
2 months ago
Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)
GlobeNewswire
2 months ago
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
Compare ACOG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACOG Alpha Cognition Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.